Antibody-mediated immunity against tuberculosis: Implications for vaccine development

Cell Host and Microbe

Volumn 13, Issue 3, 2013, Pages 250-262

  Achkar, Jacqueline M ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN 85A; ANTIGEN 85B; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BCG VACCINE; CHOLERA TOXIN; CULTURE FILTRATE PROTEIN 10; CULTURE FILTRATE PROTEIN 21; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2E9; MONOCLONAL ANTIBODY 4057; MONOCLONAL ANTIBODY 9D8; MONOCLONAL ANTIBODY MBS43; MONOCLONAL ANTIBODY SMITH14; MONOCLONAL ANTIBODY TBA61; MONOCLONAL ANTIBODY TBA84; MPT83 ANTIGEN; MYCOBACTERIUM VACCINE; RECOMBINANT PSEUDOMONAS AERUGINOSA EXOTOXIN A; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BCG VACCINATION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; DRUG DESIGN; DRUG EFFICACY; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; INNATE IMMUNITY; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPSONIZATION; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; QUORUM SENSING; TUBERCULOSIS;

EID: 84875141413     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2013.02.009     Document Type: Review

References (97)

1. F. Abebe, and G. Bjune The protective role of antibody responses during Mycobacterium tuberculosis infection Clin. Exp. Immunol. 157 2009 235 243
2. J.M. Achkar, and E.R. Jenny-Avital Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response J. Infect. Dis. 204 Suppl 4 2011 S1179 S1186
3. J.M. Achkar, E. Jenny-Avital, X. Yu, S. Burger, E. Leibert, P.W. Bilder, S.C. Almo, A. Casadevall, and S. Laal Antibodies against immunodominant antigens of Mycobacterium tuberculosis in subjects with suspected tuberculosis in the United States compared by HIV status Clin. Vaccine Immunol. 17 2010 384 392
4. L.P. Almeida, A.P. Trombone, J.C. Lorenzi, C.D. Rocha, T. Malardo, I.C. Fontoura, A.F. Gembre, R.L. Silva, C.L. Silva, A.P. Castelo, and A.A. Coelho-Castelo B cells can modulate the CD8 memory T cell after DNA vaccination against experimental tuberculosis Genet. Vaccines Ther. 9 2011 5 10.1186/1479-0556-9-5
5. J.A. Armstrong, and P.D. Hart Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival J. Exp. Med. 142 1975 1 16
6. M. Ballow The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders J. Allergy Clin. Immunol. 127 2011 315 323
7. S. Balu, R. Reljic, M.J. Lewis, R.J. Pleass, R. McIntosh, C. van Kooten, M. van Egmond, S. Challacombe, J.M. Woof, and J. Ivanyi A novel human IgA monoclonal antibody protects against tuberculosis J. Immunol. 186 2011 3113 3119
8. U. Beyazova, S. Rota, C. Cevheroǧlu, and T. Karsligil Humoral immune response in infants after BCG vaccination Tuber. Lung Dis. 76 1995 248 253
9. K. Boggian, W. Fierz, and P.L. Vernazza Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study J. Clin. Microbiol. 34 1996 1854 1855
10. C.M. Bosio, D. Gardner, and K.L. Elkins Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology J. Immunol. 164 2000 6417 6425
11. R.M. Brown, O. Cruz, M. Brennan, M.L. Gennaro, L. Schlesinger, Y.A. Skeiky, and D.F. Hoft Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination J. Infect. Dis. 187 2003 513 517
12. S. Buccheri, R. Reljic, N. Caccamo, J. Ivanyi, M. Singh, A. Salerno, and F. Dieli IL-4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c mice Eur. J. Immunol. 37 2007 729 737
13. S. Buccheri, R. Reljic, N. Caccamo, S. Meraviglia, J. Ivanyi, A. Salerno, and F. Dieli Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy Tuberculosis (Edinb.) 89 2009 91 94
14. M.V. Carroll, N. Lack, E. Sim, A. Krarup, and R.B. Sim Multiple routes of complement activation by Mycobacterium bovis BCG Mol. Immunol. 46 2009 3367 3378
15. A. Casadevall Antibody immunity and invasive fungal infections Infect. Immun. 63 1995 4211 4218
16. A. Casadevall Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle Infect. Immun. 71 2003 4225 4228
17. A. Casadevall The methodology for determining the efficacy of antibody-mediated immunity J. Immunol. Methods 291 2004 1 10
18. A. Casadevall, and L.A. Pirofski The damage-response framework of microbial pathogenesis Nat. Rev. Microbiol. 1 2003 17 24
19. A. Casadevall, and L.A. Pirofski Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases Cell Host Microbe 11 2012 447 456
20. A. Casadevall, and L.A. Pirofski A new synthesis for antibody-mediated immunity Nat. Immunol. 13 2012 21 28
21. A. Cassone, and A. Casadevall Recent progress in vaccines against fungal diseases Curr. Opin. Microbiol. 15 2012 427 433
22. CDC (2012). Vaccines and immunizations: rubella. http://www.cdc.gov/ vaccines/pubs/pinkbook/rubella.html#.
23. M.A. Chambers, D. Gavier-Widén, and R.G. Hewinson Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge FEMS Immunol. Med. Microbiol. 41 2004 93 100
24. S. Chang-hong, W. Xiao-wu, Z. Hai, Z. Ting-fen, W. Li-Mei, and X. Zhi-kai Immune responses and protective efficacy of the gene vaccine expressing Ag85B and ESAT6 fusion protein from Mycobacterium tuberculosis DNA Cell Biol. 27 2008 199 207
25. A.M. Checkley, and H. McShane Tuberculosis vaccines: progress and challenges Trends Pharmacol. Sci. 32 2011 601 606
26. C.L. Ciurana, B. Zwart, G. van Mierlo, and C.E. Hack Complement activation by necrotic cells in normal plasma environment compares to that by late apoptotic cells and involves predominantly IgM Eur. J. Immunol. 34 2004 2609 2619
27. G.A. Colditz, T.F. Brewer, C.S. Berkey, M.E. Wilson, E. Burdick, H.V. Fineberg, and F. Mosteller Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature JAMA 271 1994 698 702
28. F.M. Collins Vaccines and cell-mediated immunity Bacteriol. Rev. 38 1974 371 402
29. S. Conti, F. Fanti, W. Magliani, M. Gerloni, D. Bertolotti, A. Salati, A. Cassone, and L. Polonelli Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies J. Infect. Dis. 177 1998 807 811
30. A.M. Costello, A. Kumar, V. Narayan, M.S. Akbar, S. Ahmed, C. Abou-Zeid, G.A. Rook, J. Stanford, and C. Moreno Does antibody to mycobacterial antigens, including lipoarabinomannan, limit dissemination in childhood tuberculosis? Trans. R. Soc. Trop. Med. Hyg. 86 1992 686 692
31. A.T. Cruz, and J.R. Starke Clinical manifestations of tuberculosis in children Paediatr. Respir. Rev. 8 2007 107 117
32. J.M. Davis, and L. Ramakrishnan The role of the granuloma in expansion and dissemination of early tuberculous infection Cell 136 2009 37 49
33. R. Dayal, A. Singh, V.M. Katoch, B. Joshi, D.S. Chauhan, P. Singh, G. Kumar, and V.D. Sharma Serological diagnosis of tuberculosis Indian J. Pediatr. 75 2008 1219 1221
34. S. de Vallière, G. Abate, A. Blazevic, R.M. Heuertz, and D.F. Hoft Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies Infect. Immun. 73 2005 6711 6720
35. G. Di Perri, A. Cazzadori, S. Vento, S. Bonora, M. Malena, L. Bontempini, M. Lanzafame, B. Allegranzi, and E. Concia Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients Tuber. Lung Dis. 77 1996 244 249
36. R. Diel, R. Loddenkemper, S. Niemann, K. Meywald-Walter, and A. Nienhaus Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update Am. J. Respir. Crit. Care Med. 183 2011 88 95
37. P.R. Donald, B.J. Marais, and C.E. Barry 3rd Age and the epidemiology and pathogenesis of tuberculosis Lancet 375 2010 1852 1854
38. B.T. Edelson, P. Cossart, and E.R. Unanue Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection J. Immunol. 163 1999 4087 4090
39. L. Encinales, J. Zuñiga, J. Granados-Montiel, M. Yunis, J. Granados, I. Almeciga, O. Clavijo, C. Awad, V. Collazos, and M.I. Vargas-Rojas Humoral immunity in tuberculin skin test anergy and its role in high-risk persons exposed to active tuberculosis Mol. Immunol. 47 2010 1066 1073
40. P.K. Giri, I. Verma, and G.K. Khuller Enhanced immunoprotective potential of Mycobacterium tuberculosis Ag85 complex protein based vaccine against airway Mycobacterium tuberculosis challenge following intranasal administration FEMS Immunol. Med. Microbiol. 47 2006 233 241
41. A. Glatman-Freedman The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy Tuberculosis (Edinb.) 86 2006 191 197
42. A. Glatman-Freedman, and A. Casadevall Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis Clin. Microbiol. Rev. 11 1998 514 532
43. A. Glatman-Freedman, A.J. Mednick, N. Lendvai, and A. Casadevall Clearance and organ distribution of Mycobacterium tuberculosis lipoarabinomannan (LAM) in the presence and absence of LAM-binding immunoglobulin M Infect. Immun. 68 2000 335 341
44. A. Glatman-Freedman, A. Casadevall, Z. Dai, W.R. Jacobs Jr., A. Li, S.L. Morris, J.A. Navoa, S. Piperdi, J.B. Robbins, and R. Schneerson Antigenic evidence of prevalence and diversity of Mycobacterium tuberculosis arabinomannan J. Clin. Microbiol. 42 2004 3225 3231
45. A. Grover, M.F. Ahmed, B. Singh, I. Verma, P. Sharma, and G.K. Khuller A multivalent combination of experimental antituberculosis DNA vaccines based on Ag85B and regions of difference antigens Microbes Infect. 8 2006 2390 2399
46. E. Guirado, I. Amat, O. Gil, J. Díaz, V. Arcos, N. Caceres, V. Ausina, and P.J. Cardona Passive serum therapy with polyclonal antibodies against Mycobacterium tuberculosis protects against post-chemotherapy relapse of tuberculosis infection in SCID mice Microbes Infect. 8 2006 1252 1259
47. S. Gupta, R. Bhatia, and K.K. Datta Serological diagnosis of childhood tuberculosis by estimation of mycobacterial antigen 60-specific immunoglobulins in the serum Tuber. Lung Dis. 78 1997 21 27
48. B. Hamasur, M. Haile, A. Pawlowski, U. Schröder, A. Williams, G. Hatch, G. Hall, P. Marsh, G. Källenius, and S.B. Svenson Mycobacterium tuberculosis arabinomannan-protein conjugates protect against tuberculosis Vaccine 21 2003 4081 4093
49. B. Hamasur, M. Haile, A. Pawlowski, U. Schroder, G. Kallenius, and S.B. Svenson A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis Clin. Exp. Immunol. 138 2004 30 38
50. G. Hetland, H.G. Wiker, K. Høgåsen, B. Hamasur, S.B. Svenson, and M. Harboe Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis Clin. Diagn. Lab. Immunol. 5 1998 211 218
51. K. Huygen, J. Content, O. Denis, D.L. Montgomery, A.M. Yawman, R.R. Deck, C.M. DeWitt, I.M. Orme, S. Baldwin, and C. D'Souza Immunogenicity and protective efficacy of a tuberculosis DNA vaccine Nat. Med. 2 1996 893 898
52. J.U. Igietseme, F.O. Eko, Q. He, and C.M. Black Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens Expert Rev. Vaccines 3 2004 23 34
53. S.H. Kaufmann Fact and fiction in tuberculosis vaccine research: 10 years later Lancet Infect. Dis. 11 2011 633 640
54. A. Keyser, J.M. Troudt, J.L. Taylor, and A.A. Izzo BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity Vaccine 29 2011 9308 9315
55. H. Kohama, M. Umemura, Y. Okamoto, A. Yahagi, H. Goga, T. Harakuni, G. Matsuzaki, and T. Arakawa Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice Vaccine 26 2008 924 932
56. S. Kunnath-Velayudhan, and M.L. Gennaro Immunodiagnosis of tuberculosis: a dynamic view of biomarker discovery Clin. Microbiol. Rev. 24 2011 792 805
57. S. Kunnath-Velayudhan, H. Salamon, H.Y. Wang, A.L. Davidow, D.M. Molina, V.T. Huynh, D.M. Cirillo, G. Michel, E.A. Talbot, and M.D. Perkins Dynamic antibody responses to the Mycobacterium tuberculosis proteome Proc. Natl. Acad. Sci. USA 107 2010 14703 14708
58. S. Kunnath-Velayudhan, A.L. Davidow, H.Y. Wang, D.M. Molina, V.T. Huynh, H. Salamon, R. Pine, G. Michel, M.D. Perkins, and L. Xiaowu Proteome-scale antibody responses and outcome of Mycobacterium tuberculosis infection in nonhuman primates and in tuberculosis patients J. Infect. Dis. 206 2012 697 705
59. P.L. Lin, M. Rodgers, L. Smith, M. Bigbee, A. Myers, C. Bigbee, I. Chiosea, S.V. Capuano, C. Fuhrman, E. Klein, and J.L. Flynn Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model Infect. Immun. 77 2009 4631 4642
60. Y. López, D. Yero, G. Falero-Diaz, N. Olivares, M.E. Sarmiento, S. Sifontes, R.L. Solis, J.A. Barrios, D. Aguilar, R. Hernández-Pando, and A. Acosta Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection Int. J. Med. Microbiol. 299 2009 447 452
61. A. Lux, S. Aschermann, M. Biburger, and F. Nimmerjahn The pro and anti-inflammatory activities of immunoglobulin G Ann. Rheum. Dis. 69 Suppl 1 2010 i92 i96
62. K. Lyashchenko, R. Colangeli, M. Houde, H. Al Jahdali, D. Menzies, and M.L. Gennaro Heterogeneous antibody responses in tuberculosis Infect. Immun. 66 1998 3936 3940
63. K.P. Lyashchenko, R. Greenwald, J. Esfandiari, M.A. Chambers, J. Vicente, C. Gortazar, N. Santos, M. Correia-Neves, B.M. Buddle, and R. Jackson Animal-side serologic assay for rapid detection of Mycobacterium bovis infection in multiple species of free-ranging wildlife Vet. Microbiol. 132 2008 283 292
64. P.J. Maglione, and J. Chan How B cells shape the immune response against Mycobacterium tuberculosis Eur. J. Immunol. 39 2009 676 686
65. P.J. Maglione, J. Xu, and J. Chan B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis J. Immunol. 178 2007 7222 7234
66. P.J. Maglione, J. Xu, A. Casadevall, and J. Chan Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection J. Immunol. 180 2008 3329 3338
67. Z.A. Malik, G.M. Denning, and D.J. Kusner Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages J. Exp. Med. 191 2000 287 302
68. S. Manivannan, N.V. Rao, and V.D. Ramanathan Role of complement activation and antibody in the interaction between Mycobacterium tuberculosis and human macrophages Indian J. Exp. Biol. 50 2012 542 550
69. E.E. McClelland, A.M. Nicola, R. Prados-Rosales, and A. Casadevall Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism J. Clin. Invest. 120 2010 1355 1361
70. M.D. Mossalayi, I. Vouldoukis, M. Mamani-Matsuda, T. Kauss, J. Guillon, J. Maugein, D. Moynet, J. Rambert, V. Desplat, and D. Mazier CD23 mediates antimycobacterial activity of human macrophages Infect. Immun. 77 2009 5537 5542
71. J.A. Navoa, S. Laal, L.A. Pirofski, G.R. McLean, Z. Dai, J.B. Robbins, R. Schneerson, A. Casadevall, and A. Glatman-Freedman Specificity and diversity of antibodies to Mycobacterium tuberculosis arabinomannan Clin. Diagn. Lab. Immunol. 10 2003 88 94
72. H. Niu, L. Hu, Q. Li, Z. Da, B. Wang, K. Tang, Q. Xin, H. Yu, Y. Zhang, and Y. Wang Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX Vaccine 29 2011 9451 9458
73. J.D. Nosanchuk, J.N. Steenbergen, L. Shi, G.S. Deepe Jr., and A. Casadevall Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum J. Clin. Invest. 112 2003 1164 1175
74. N. Olivares, A. León, Y. López, A. Puig, A. Cádiz, G. Falero, M. Martínez, M.E. Sarmiento, M. Fariñas, and J.F. Infante The effect of the administration of human gamma globulins in a model of BCG infection in mice Tuberculosis (Edinb.) 86 2006 268 272
75. C. Palma, E. Iona, F. Giannoni, M. Pardini, L. Brunori, L. Fattorini, G. Del Giudice, and A. Cassone The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response Vaccine 26 2008 4237 4243
76. K. Pethe, S. Alonso, F. Biet, G. Delogu, M.J. Brennan, C. Locht, and F.D. Menozzi The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination Nature 412 2001 190 194
77. J.B. Robbins, R. Schneerson, and S.C. Szu Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum J. Infect. Dis. 171 1995 1387 1398
78. A. Rodríguez, A. Tjärnlund, J. Ivanji, M. Singh, I. García, A. Williams, P.D. Marsh, M. Troye-Blomberg, and C. Fernández Role of IgA in the defense against respiratory infections IgA deficient mice exhibited increased susceptibility to intranasal infection with Mycobacterium bovis BCG Vaccine 23 2005 2565 2572
79. E. Roy, E. Stavropoulos, J. Brennan, S. Coade, E. Grigorieva, B. Walker, B. Dagg, R.E. Tascon, D.B. Lowrie, M.J. Colston, and S. Jolles Therapeutic efficacy of high-dose intravenous immunoglobulin in Mycobacterium tuberculosis infection in mice Infect. Immun. 73 2005 6101 6109
80. E.J. Rubin The granuloma in tuberculosis - friend or foe? N. Engl. J. Med. 360 2009 2471 2473
81. R.T. Russo, and M. Mariano B-1 cell protective role in murine primary Mycobacterium bovis bacillus Calmette-Guerin infection Immunobiology 215 2010 1005 1014
82. E. Sada, L.E. Ferguson, and T.M. Daniel An ELISA for the serodiagnosis of tuberculosis using a 30,000-Da native antigen of Mycobacterium tuberculosis J. Infect. Dis. 162 1990 928 931
83. B.M. Saunders, and A.M. Cooper Restraining mycobacteria: role of granulomas in mycobacterial infections Immunol. Cell Biol. 78 2000 334 341
84. J.R. Schwebach The carbohydrate surface of M. tuberculosis: antigenicity and antibody immunity Sue Golding Graduate Division of Medical Sciences 2002 Albert Einstein College of Medicine Bronx, NY
85. K.R. Steingart, N. Dendukuri, M. Henry, I. Schiller, P. Nahid, P.C. Hopewell, A. Ramsay, M. Pai, and S. Laal Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis Clin. Vaccine Immunol. 16 2009 260 276
86. M. Suga, F. Tanaka, H. Muranaka, H. Nishikawa, and M. Ando Effect of antibacterial antibody on bactericidal activities of superoxide and lysosomal enzyme from alveolar macrophages in rabbits Respirology 1 1996 127 132
87. R. Teitelbaum, A. Glatman-Freedman, B. Chen, J.B. Robbins, E. Unanue, A. Casadevall, and B.R. Bloom A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival Proc. Natl. Acad. Sci. USA 95 1998 15688 15693
88. F.M. Teixeira, H.C. Teixeira, A.P. Ferreira, M.F. Rodrigues, V. Azevedo, G.C. Macedo, and S.C. Oliveira DNA vaccine using Mycobacterium bovis Ag85B antigen induces partial protection against experimental infection in BALB/c mice Clin. Vaccine Immunol. 13 2006 930 935
89. A. Tjärnlund, A. Rodríguez, P.J. Cardona, E. Guirado, J. Ivanyi, M. Singh, M. Troye-Blomberg, and C. Fernández Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice Int. Immunol. 18 2006 807 816
90. H.M. Vordermeier, N. Venkataprasad, D.P. Harris, and J. Ivanyi Increase of tuberculous infection in the organs of B cell-deficient mice Clin. Exp. Immunol. 106 1996 312 316
91. I. Vouldoukis, D. Mazier, D. Moynet, D. Thiolat, D. Malvy, and M.D. Mossalayi IgE mediates killing of intracellular Toxoplasma gondii by human macrophages through CD23-dependent, interleukin-10 sensitive pathway PLoS ONE 6 2011 e18289 10.1371/journal.pone.0018289
92. A. Williams, R. Reljic, I. Naylor, S.O. Clark, G. Falero-Diaz, M. Singh, S. Challacombe, P.D. Marsh, and J. Ivanyi Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs Immunology 111 2004 328 333
93. World Health Organization (2012). Global tuberculosis report 2012. Geneva, Switzerland. http://www.who.int/tb/publications/global-report/.
94. T. Xue, E. Stavropoulos, M. Yang, S. Ragno, M. Vordermeier, M. Chambers, G. Hewinson, D.B. Lowrie, M.J. Colston, and R.E. Tascon RNA encoding the MPT83 antigen induces protective immune responses against Mycobacterium tuberculosis infection Infect. Immun. 72 2004 6324 6329
95. M. Yano, S. Gohil, J.R. Coleman, C. Manix, and L.A. Pirofski Antibodies to Streptococcus pneumoniae capsular polysaccharide enhance pneumococcal quorum sensing mBio. 2 2011 10.1128/mBio.00176-11 e00176-11
96. X. Yu, R. Prados-Rosales, E.R. Jenny-Avital, K. Sosa, A. Casadevall, and J.M. Achkar Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status Clin. Vaccine Immunol. 19 2012 198 208
97. M. Zhang, X. Zheng, J. Zhang, Y. Zhu, X. Zhu, H. Liu, M. Zeng, M.W. Graner, B. Zhou, and X. Chen CD19(+)CD1d(+)CD5(+) B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses Cell. Immunol. 274 2012 89 97